Similar articles

• Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.

  Polli EE, Cortellaro M. Polli EE, et al. Haematologica. 1980 Jun;65(3):361-9. Haematologica. 1980. PMID: 6778788 Review. No abstract available.
• Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.

  Jhawar BK, Trivedi HH, Bhargava RK, Misra NP. Jhawar BK, et al. J Assoc Physicians India. 1978 Sep;26(9):805-9. J Assoc Physicians India. 1978. PMID: 370078 Clinical Trial. No abstract available.
• [The use of platelet aggregation-inhibiting drugs in central vestibular pathology caused by atherosclerotic vascular diseases].

  Borasi G, Pallestrini EA, Sperati G. Borasi G, et al. Ann Laringol Otol Rinol Faringol. 1975;74(6):443-53. Ann Laringol Otol Rinol Faringol. 1975. PMID: 25036 Italian. No abstract available.
• [Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease].

  Gryglik J. Gryglik J. Pol Tyg Lek. 1979 Mar 26;34(13):509-11. Pol Tyg Lek. 1979. PMID: 375209 Review. Polish. No abstract available.
• Aspirin and other platelet-aggregation inhibiting drugs.

  Gallus AS. Gallus AS. Med J Aust. 1985 Jan 7;142(1):41-7. Med J Aust. 1985. PMID: 3880861 Review.